Is Immunome, Inc. technically bullish or bearish?

As of 22 August 2025, the technical trend for Immunome, Inc. has changed from bearish to mildly bullish. The weekly MACD is bullish, while the monthly MACD remains bearish, indicating mixed signals across time frames. The daily moving averages are mildly bullish, supporting the current positive trend. However, the weekly KST is bullish and the monthly KST is bearish, further contributing to the mixed outlook. The Bollinger Bands show a bullish stance weekly but mildly bearish monthly, and the OBV is mildly bearish weekly while mildly bullish monthly.
In terms of performance, Immunome's returns have been underwhelming compared to the S&P 500, with a year-to-date return of -7.25% versus the S&P's 12.22%, and a one-year return of -36.45% compared to the S&P's 17.14%. Overall, the current stance is mildly bullish, but caution is warranted due to the mixed indicators and underperformance relative to the benchmark.